The enzyme, MINPP1, regulates the catalyzation from 2, 3‐BPG to 2‐PG, participates in glycolytic bypass, and inhibits cancer cell growth in hepatitis B virus‐related hepatocellular carcinoma (Chen et al., 2021). Here, MINPP1 is linked to hepatocellular carcinoma.